InMed Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

InMed Pharmaceuticals

13/05/2022 15:11

* InMed Pharmaceuticals Inc  INM.OQ  reported a quarterly
adjusted
loss of 25 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 25 cents per share.
    * Revenue was $309.59 thousand​;  analysts expected $600.00
thousand. 
    * InMed Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 25 cents​.
    * The mean earnings estimate of analysts had fallen by
about 16.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * InMed Pharmaceuticals Inc shares had fallen by 14.1% this
quarter and lost 38.2% so far this year.
    * The company reported a quarterly loss of $3.48 million.
    * Wall Street's median 12-month price target for InMed
Pharmaceuticals Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 02:11 p.m.  ​All
figures in US dollars unless otherwise stated